175 related articles for article (PubMed ID: 14623536)
1. Aromatase in bone: roles of Vitamin D3 and androgens.
Yanase T; Suzuki S; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):393-7. PubMed ID: 14623536
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts.
Takayanagi R; Goto K; Suzuki S; Tanaka S; Shimoda S; Nawata H
Mech Ageing Dev; 2002 Apr; 123(8):1107-14. PubMed ID: 12044960
[TBL] [Abstract][Full Text] [Related]
3. Aromatase in bone cell: association with osteoporosis in postmenopausal women.
Nawata H; Tanaka S; Tanaka S; Takayanagi R; Sakai Y; Yanase T; Ikuyama S; Haji M
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):165-74. PubMed ID: 7626449
[TBL] [Abstract][Full Text] [Related]
4. [DHEA and bone metabolism].
Yanase T; Suzuki S; Goto K; Nawata H; Takayanagi R
Clin Calcium; 2003 Nov; 13(11):1419-24. PubMed ID: 15775227
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts.
Tanaka S; Haji M; Takayanagi R; Tanaka S; Sugioka Y; Nawata H
Endocrinology; 1996 May; 137(5):1860-9. PubMed ID: 8612525
[TBL] [Abstract][Full Text] [Related]
6. [Role of androgens and DHEA in bone metabolism].
Adachi M; Takayanagi R
Clin Calcium; 2006 Jan; 16(1):61-6. PubMed ID: 16397352
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.
Wang L; Wang YD; Wang WJ; Li DJ
Osteoporos Int; 2009 Jan; 20(1):79-92. PubMed ID: 18690485
[TBL] [Abstract][Full Text] [Related]
8. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function.
Janssen JM; Bland R; Hewison M; Coughtrie MW; Sharp S; Arts J; Pols HA; van Leeuwen JP
J Cell Biochem; 1999 Dec; 75(3):528-37. PubMed ID: 10536374
[TBL] [Abstract][Full Text] [Related]
9. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
[TBL] [Abstract][Full Text] [Related]
10. Ample Evidence: Dehydroepiandrosterone (DHEA) Conversion into Activated Steroid Hormones Occurs in Adrenal and Ovary in Female Rat.
Zhou Y; Kang J; Chen D; Han N; Ma H
PLoS One; 2015; 10(5):e0124511. PubMed ID: 25962158
[TBL] [Abstract][Full Text] [Related]
11. Characterization of aromatase and 17 beta-hydroxysteroid dehydrogenase expression in rat osteoblastic cells.
Eyre LJ; Bland R; Bujalska IJ; Sheppard MC; Stewart PM; Hewison M
J Bone Miner Res; 1998 Jun; 13(6):996-1004. PubMed ID: 9626631
[TBL] [Abstract][Full Text] [Related]
12. Androstenedione increases cytochrome P450 aromatase messenger ribonucleic acid transcripts in nonluteinizing bovine granulosa cells.
Hamel M; Vanselow J; Nicola ES; Price CA
Mol Reprod Dev; 2005 Feb; 70(2):175-83. PubMed ID: 15570613
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells.
Shozu M; Zhao Y; Simpson ER
Mol Cell Endocrinol; 2000 Feb; 160(1-2):123-33. PubMed ID: 10715546
[TBL] [Abstract][Full Text] [Related]
14. Aromatase expression of human osteoblast-like cells.
Shozu M; Simpson ER
Mol Cell Endocrinol; 1998 Apr; 139(1-2):117-29. PubMed ID: 9705080
[TBL] [Abstract][Full Text] [Related]
15. Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.
Vermeulen A; Deslypere JP; Paridaens R; Leclercq G; Roy F; Heuson JC
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):515-25. PubMed ID: 3015631
[TBL] [Abstract][Full Text] [Related]
16. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
[TBL] [Abstract][Full Text] [Related]
17. 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism.
Lundqvist J; Norlin M; Wikvall K
Biochim Biophys Acta; 2011 Apr; 1811(4):263-70. PubMed ID: 21262387
[TBL] [Abstract][Full Text] [Related]
18. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
19. Fat tissue: a steroid reservoir and site of steroid metabolism.
Deslypere JP; Verdonck L; Vermeulen A
J Clin Endocrinol Metab; 1985 Sep; 61(3):564-70. PubMed ID: 3160722
[TBL] [Abstract][Full Text] [Related]
20. Aromatase and steroid sulfatase from human placenta.
Ghosh D
Methods Enzymol; 2023; 689():67-86. PubMed ID: 37802583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
